GCA
VRTX icon

Greenwood Capital Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.58M Sell
10,298
-1,595
-13% -$710K 0.57% 61
2025
Q1
$5.77M Sell
11,893
-6,572
-36% -$3.19M 0.78% 41
2024
Q4
$7.44M Sell
18,465
-2,059
-10% -$829K 0.97% 33
2024
Q3
$9.55M Sell
20,524
-669
-3% -$311K 1.24% 16
2024
Q2
$9.93M Buy
21,193
+1,058
+5% +$496K 1.31% 16
2024
Q1
$8.42M Sell
20,135
-5,210
-21% -$2.18M 1.12% 24
2023
Q4
$10.3M Buy
25,345
+2,576
+11% +$1.05M 1.34% 13
2023
Q3
$7.92M Sell
22,769
-5,429
-19% -$1.89M 1.15% 24
2023
Q2
$9.92M Sell
28,198
-315
-1% -$111K 1.39% 14
2023
Q1
$8.98M Buy
28,513
+370
+1% +$117K 1.29% 20
2022
Q4
$8.13M Sell
28,143
-2,276
-7% -$657K 1.33% 27
2022
Q3
$8.81M Sell
30,419
-774
-2% -$224K 1.51% 15
2022
Q2
$8.79M Buy
31,193
+30,938
+12,133% +$8.72M 1.41% 21
2022
Q1
$67K Sell
255
-55,061
-100% -$14.5M 0.02% 166
2021
Q4
$12.1M Sell
55,316
-232
-0.4% -$50.9K 1.72% 13
2021
Q3
$10.1M Buy
55,548
+6,219
+13% +$1.13M 1.55% 16
2021
Q2
$9.95M Buy
49,329
+27,202
+123% +$5.48M 1.5% 19
2021
Q1
$4.76M Buy
22,127
+2,298
+12% +$494K 0.75% 43
2020
Q4
$4.69M Buy
+19,829
New +$4.69M 0.79% 45
2017
Q3
Sell
-1,897
Closed -$244K 226
2017
Q2
$244K Buy
+1,897
New +$244K 0.06% 156
2016
Q1
Sell
-10,768
Closed -$1.36M 179
2015
Q4
$1.36M Buy
10,768
+80
+0.7% +$10.1K 0.44% 77
2015
Q3
$1.11M Sell
10,688
-11,032
-51% -$1.15M 0.39% 71
2015
Q2
$2.68M Sell
21,720
-892
-4% -$110K 0.81% 52
2015
Q1
$2.67M Sell
22,612
-23,930
-51% -$2.82M 0.76% 60
2014
Q4
$5.53M Buy
46,542
+5,038
+12% +$598K 1.6% 16
2014
Q3
$4.66M Buy
+41,504
New +$4.66M 1.43% 21
2013
Q4
Sell
-2,845
Closed -$216K 115
2013
Q3
$216K Buy
+2,845
New +$216K 0.08% 98